It’s happening!!!! 2022 ESC Guidelines on cardio-oncology developed in collaboration with the(ESTRO) and the International Cardio-Oncology Society (IC-OS) @drbrowncares @JoEllen_Rodgers https://t.co/OCtqFKS7MO
The new Heart Failure Guideline developed by @ACCinTouch@American_Heart and @HFSA was published today in @JCardFail
Guideline > https://t.co/uVMA9NZENR
Clinician's Guide > https://t.co/2tC6HIDcYF
Executive Summary > https://t.co/M8mgq4chms
Today’s #HFrEF fact about MRAs: “Mean SBP change from baseline to 6 months was +1.4 ± 18.1 mm Hg in the placebo group and −1.2 ± 17.9 mm Hg in the MRA group.” - don’t count out spironolactone and its early mortality benefit for borderline BPs! https://t.co/f48ckIWgLM
W-O-W 😮. This incredible #teachingtuesday brought to you by @rachelrob24 highlights the exciting results from the DOREMI trial. Have the results of this trial changed your practice? Comment below ⬇️
We're expanding coverage! Hiring 2 overnight EM clinical pharmacists, 7on/7off
Come join a great team in a progressive, busy ED! #TwitteRx
https://t.co/cU6igqoq3Y
Please share this information with any final year pharmacy students who are interested in PGY1. We would love to meet them to talk about our AWESOME program at SJHMC ☀️🌵